Business Wire

Klick Health Stacks Bench in London to Support Global Business Growth and Expansion

Share

Klick Health today shared new details about the ongoing build-out of its global ecosystem, differentiated by its singular focus on health and improved patient outcomes, authentic integration modus operandi, and longstanding commitment to providing unmatched client experience. The large independent agency announced its UK-based leadership team for Europe, the Middle East, and Africa (EMEA). The news follows the appointment of EMEA Managing Director Jennifer Lambert and debut of Klick’s Asia-Pacific (APAC) hub in Singapore.

Lambert is joined in the London hub by industry veterans Ankita Batla, January Coyle, Preeti Moseman, Tara Page, Michael Smith, and Adrian Swift, as the team celebrates 13 wins at last week’s Creative Floor Awards and its stellar showing at the Cannes Lions International Festival of Creativity.

“We are thrilled to be building the most innovative life sciences agency model EMEA has ever seen. While most global agencies tend to force-fit their services together, Klick teams are integrated from the start. Based on our clients’ needs, we provide them with bespoke end-to-end services to ensure authentic and borderless solutions,” Lambert said. “I am proud of the work our team is doing. In Preeti, Tara, Michael, Adrian, Ankita, and January, we have proven leaders from both the agency and client side, who deliver solutions that amplify our clients’ success.”

Lambert introduced Klick’s EMEA leadership team:

Preeti Moseman – Senior Creative Lead, EMEA  
Moseman marks her return to the UK as Senior Creative Lead in London, following two years serving as a Creative Director on Klick’s New York team. An award-winning creative with over 16 years of industry experience, Moseman previously held positions at London agencies, EG+ (TBWA) and Wunderman, where she worked for a range of clients, including GSK, Johnson & Johnson, Pepsico, and Microsoft. Within the healthcare sector specifically, she has played senior creative roles on global launches in immunology, vaccines, and women’s health.

“I joined Klick because its drive for innovation aligns with my passion for crafting engaging experiences,” Moseman said. “With a multitude of diverse, global perspectives and reach, Klick offers the perfect stage to foster creativity, build impactful cross-functional teams, and collaborate on successful campaigns for our clients.”

Tara Page – Vice President, Head of Client Success, EMEA  
Heading up Klick’s UK-based Client Success team, Page is a veteran healthcare communications professional with over 25 years in the field, and is responsible for delivering an exceptional end-to-end client experience. Prior to joining Klick, Page was Global Director, Client Engagement at VMLY&R Health London, preceded by Managing Director, Sudler London, where she collaborated with top-tier pharmaceutical and biotech companies across brand lifecycles, covering therapeutic areas including, cardiovascular, hematology, oncology, and rare diseases.

“Being part of building a global life sciences agency from the ground-up and being surrounded by exceptionally kind and talented people is incredibly exciting. I’m loving the collaborative environment and the bright minds at Klick, as we work with our clients to enhance health outcomes and patients’ lives in EMEA and around the world,” explained Page.

Michael Smith – Science & Regulatory Director, EMEA  
Bringing more than 17 years of experience leading in-house regulatory and healthcare compliance teams at pharmaceutical companies, Smith joins the agency world as Klick’s newest Science & Regulatory Director, EMEA. He previously served as Allergan's Director of Regulatory Affairs for the UK and Ireland. Smith has worked across aesthetic medicine, cosmetics, dermatology, medical devices, movement disorders, neurosciences, ophthalmology, and OTC, with extensive experience in UK, EU, and EMEA regulations to help ensure HCP and consumer-focussed campaigns are compliant. Smith excels in managing the complex requirements of healthcare compliance, ensuring creative teams are able to push boundaries and exceed expectations, while maintaining promotional compliance.

“I was drawn to the Klick’s team enthusiasm, professionalism, and regulatory rigour,” Smith said. “I’m excited for the opportunity to build our UK-based science and regulatory team, and serve our clients as part of the single, largest medical team integrated across a full-service agency.”

Adrian Swift – Vice President, Project Management, EMEA  
With over 20 years of experience in delivery and project management roles, Swift joins Klick as Vice President, Project Management, EMEA. A seasoned leader who has worked on brands, including Coca-Cola, Centrica, and Unilever, he is adept in agile processes and managing projects for timely delivery. During his previous role as Managing Partner and EMEA PMO at Ogilvy, Swift worked on large accounts like IBM, Nestle, and The Nightingale Hospital, and led the agency’s consolidation of three regional markets into a global hub. One of his proudest career highlights was leading the team who helped expedite the establishment of temporary hospitals in the UK during the pandemic.

“My ultimate professional goal has always been to create a meaningful impact. Joining Klick and contributing to the development of something great in EMEA is an incredible opportunity to do so,” Swift said. “I’m thrilled to be part of a company that has a true entrepreneurial spirit and unique workplace culture, and eager to share my expertise in fostering agile mindsets to ensure our clients’ success.”

To further support Klick’s ongoing global expansion, Lambert also shared the following additions to the London-based team:

Ankita Batla, MBBS, MBA – Senior Vice President , Medical Strategy, Global  
With over two decades of experience in patient engagement, health communications, and medical strategy, as well as a medical degree and an MBA, Dr. Batla specializes in research, strategy, and behaviour-change communication within pharmaceuticals, nutrition, health services, and public health and patient groups. As Klick’s Senior Vice President, Medical Strategy, Global, she focuses on the medical strategy needs of Klick’s growing number of international clients. She has also held senior medical roles at other UK-based agencies, including VMLY&R Health and WPP’s System Analytic. Prior to moving into healthcare communications, Dr. Batla served as a resident doctor in hospitals’ general medicine, pediatrics, public health, and neurology departments. As a leading expert in patient advocacy, she has served as a guest lecturer at top educational institutions in the UK, including the London School of Hygiene & Tropical Medicine, UCL Business School for Health UK, and University of West London. She is currently also pursuing her Masters degree in public health.

“A doctor by training and a patient advocate at heart, I love making connections between the numbers in science and the lived realities of people. At Klick, I have a work family that believes in this ethos,” Dr. Batla said. “Having worked and lived in different parts of the world has also given me a unique perspective in tackling health challenges and inequities across markets, and developing innovative creative strategies that can maximise access”

January Coyle – Senior Vice President, Global Strategy Enablement  
Playing a key role on Klick Health’s holistic Strategy leadership team, Coyle joins its London hub as Senior Vice President, Global Strategy Enablement to ensure the effective coordination of strategy across Klick’s global markets and regions in EMEA, APAC, and LATAM. With over 20 years of experience in life sciences market research, KOL consulting, and advertising, Coyle most recently led a strategy team in Klick’s New York office for over three years. She previously served as Saatchi & Saatchi Wellness Senior Vice President, Director of Engagement Strategy for over six years. She has worked with a wide range of brands from pre-launch through LOE across therapeutic areas that include cardiovascular, metabolic, rare disease, and oncology, focussing on reaching key stakeholders in novel and engaging ways.

“It was the people and people-first culture that initially brought me to Klick. Now, I'm beyond excited to help scale the Klick magic in other markets and drive meaningful experiences for HCPs, patients, and their involved loved ones in partnership with our clients.”

Global momentum going strong 
Today's announcement follows Klick joining the Healthcare Communications Council (HCC), one of the five European Association of Communications Agencies (EACA) councils, and it highlights the latest in a long line of global hires over the last year, as the agency continues to expand across APAC, EMEA, and LATAM. In June, Klick welcomed veteran agency leaders Mitchell Tan, Dr. Shraddha Tawate, Dr. Nevil Chimon, and Alvin Yeo to its APAC hub in Singapore.

“We are energized by our global momentum and how EMEA clients are responding to our unique agency model, end-to-end offerings, and success-driven approach,” Klick Health President Ari Schaefer said. “We’re excited by what the future holds.”

About Klick Health 
Klick Health is the world’s largest independent commercialization partner for life sciences. For over 25 years, Klick has been laser-focused on developing, launching, and supporting life sciences brands to maximize their full market potential as a core commercialization partner. Recognized by leading global advertising authorities, Klick was named 2023 Independent Agency of the Year by Clio Health; its work has also been celebrated by Cannes Lions, D&AD, The One Show, Art Directors Club, Clios, New York Festivals Health, and the Webbys. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.

About Klick Group 
The Klick Group of companies–Klick Health (including Klick Katalyst and btwelve), Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs–is an ecosystem of brilliant talent collectively working to maximize their people’s and clients’ full potential. Established in 1997, Klick has teams across North America, with offices in New York, Philadelphia, Toronto; global hubs in London, São Paulo, and Singapore; and plans to open more offices in Basel, Buenos Aires, Munich, Paris, and Tokyo. Klick has consistently been named a Best Managed Company and Great Place to Work. Over the last two years alone, the company has been recognized with almost 30 Best Workplace awards, including Best Workplaces for Women, Best Workplaces for Inclusion, Most Admired Corporate Cultures, Fast Company’s Best Workplaces for Innovators, FORTUNE’s Best Workplaces in New York, and FORTUNE’s Best Workplaces in Advertising.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PR@Klick.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Industrial 3-axis accelerometer has high offset stability24.6.2025 05:00:00 EEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has introduced a 3-axis accelerometer for the industrial market that combines high offset stability over temperature and time, good linearity, low noise density, and excellent robustness. The SCA3400-D01 XYZ accelerometer is meant for use in industrial applications such as structural health monitoring (SHM), machine control, inertial measurement units, and construction tools and systems. This product will be exhibited at Sensors Converge 2025 to be held at the Santa Clara Convention Center (Booth #716), California from 24 to 26 June 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623994075/en/ [Murata Manufacturing Co., Ltd.] Industrial 3-axis accelerometer The offset stability of an accelerometer refers to the consistency of its output when at rest, but subject to varying temperatures or the effects of aging. Ideally, this output should be zero, but i

Grid Dynamics Announces AI-Powered Engagement Model Enabling Accelerated Business Transformation for Fortune 1000 Enterprises23.6.2025 16:15:00 EEST | Press release

Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a prominent technology consulting and digital services provider specializing in AI, platform and product engineering, and digital engagement services—today announced the launch of an innovative AI-powered engagement model for its software engineering services. This new model is specifically engineered to deliver the next level of agility, quality, and accelerated time-to-market for Fortune 1000 enterprises. Grid Dynamics' innovative approach expands its engagement offerings beyond traditional Fixed Price, Time and Materials, and Capacity-based engagements. Key features include: Prompt-driven incremental output: Delivering value through iterative, prompt-guided development. Credit-based service consumption: Pricing aligned with desired outputs rather than effort—offering cost efficiency. AI-benchmarked code quality: Continuous evaluation against industry and client standards—ensuring code quality. Centralized client portal: A s

Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges23.6.2025 15:05:00 EEST | Press release

As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper examining the opportunities and challenges shaping this fast-evolving landscape of therapeutic class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623205345/en/ LBPs, which harness live microorganisms to restore or modulate human health, are being explored across a growing range of indications, from gastrointestinal and metabolic disorders to CNS and oncology. FDA approvals of Rebyota™ and Vowst™ have validated the category but for most biotech sponsors, the journey remains uncertain. According to Novotech’s analysis, over 90% of LBP assets are still in early development stages, and nearly one-third of all trials from 2020 to 2025 have been withdrawn or suspended due to regulatory, manufacturing, or design complexities. Highli

Sagemcom’s Net Zero Trajectory Approved by SBTi: Target Set for 204023.6.2025 15:00:00 EEST | Press release

Sagemcom Group has today reached a critical milestone in its climate strategy: its Net Zero carbon target for 2040—encompassing all activities and sites within the Group’s consolidated scope—has been officially validated by the Science Based Targets initiative (SBTi). This international endorsement attests to the scientific rigor of Sagemcom’s decarbonization strategy, aligned with the Paris Agreement’s ambition to limit global warming to 1.5°C. It strengthens the Group’s comprehensive climate roadmap, which is built on a significant reduction of greenhouse gas emissions across all scopes: By 2030: A 47% absolute reduction in Scope 1 and Scope 2 emissions (direct emissions and purchased energy), 100% renewable energy consumption across all Group sites, A 31% absolute reduction in Scope 3 emissions, including those related to the value chain, with no exclusion of any greenhouse gas categories. By 2040: Achievement of Net Zero, corresponding to a 90% absolute reduction in total Group emi

One, Two, Three-Peat: Mary Kay Inc. Named #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World for Three Years in a Row23.6.2025 15:00:00 EEST | Press release

Good things come in threes: iconic beauty brand and global entrepreneurship company Mary Kay Inc. has again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International for the third consecutive year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623000452/en/ Ryan Rogers, Chief Executive Officer of Mary Kay states: "Being named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World by Euromonitor International three years in a row marks a grand slam achievement for Mary Kay. This repeated milestone reflects years of R&D and marketing efforts to create skin and beauty solutions that meet consumer needs and are loved the world-over. Above all, it demonstrates the transformative power of our Independent Beauty Consultants who are driving this success globally." (Photo Courtesy: Mary Kay Inc.) Euromonitor International is the foremost provider of globa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye